Such an example is dopastatin, a chemical compound combining the structure of dopamine and somatostatin; the use of this compound was envisaged as a therapeutic agent in patients with acromegaly, and indeed, its ability to act both on SSTR2 and dopamine D2 receptors was found to greatly enhance its effects [473,474]. The gene discussed is DRD2; the disease is acromegaly.